A classic T-cell phenotype in systemic lupus erythematosus (SLE) is the downregulation and replacement of the CD3ζ chain that alters T-cell receptor signaling. However, genetic associations with SLE in the human CD247 locus that encodes CD3ζ are not well established and require replication in independent cohorts. Our aim was therefore to examine, localize and validate CD247-SLE association in a large multiethnic population. We typed 44 contiguous CD247 single-nucleotide polymorphisms (SNPs) in 8922 SLE patients and 8077 controls from four ethnically distinct populations. The strongest associations were found in the Asian population (11 SNPs in intron 1, 4.99 × 10 − 4 o Po 4.15 × 10 − 2 ), where we further identified a five-marker haplotype (rs12141731-rs2949655-rs16859085-rs12144621-rs858554; G-G-A-G-A; P hap = 2.12 × 10 − 5 ) that exceeded the most associated single SNP rs858554 (minor allele frequency in controls = 13%; P = 4.99 × 10 − 4 , odds ratio = 1.32) in significance. Imputation and subsequent association analysis showed evidence of association (P o 0.05) at 27 additional SNPs within intron 1. Cross-ethnic meta-analysis, assuming an additive genetic model adjusted for population proportions, showed five SNPs with significant P-values (1.40 × 10 − 3 o P o3.97 × 10 − 2 ), with one (rs704848) remaining significant after Bonferroni correction (P meta = 2.66 × 10 − 2 ). Our study independently confirms and extends the association of SLE with CD247, which is shared by various autoimmune disorders and supports a common T-cellmediated mechanism.
INTRODUCTION
Systemic lupus erythematosus (SLE; OMIM 152700) is a chronic and potentially fatal autoimmune disorder characterized by the production of autoantibodies that cause widespread tissue damage. T-cells from patients with SLE have a number of phenotypic and functional abnormalities. 1, 2 Some of the strongest confirmed genetic associations with SLE obviously affect T-cells, including HLA class II, which still exceeds all other associations in significance, as well as PTPN22, a T-cell receptor (TCR) signal modifier, 3 and PTTG1 affecting miR146a 4 that appears particularly relevant for regulatory T-cells. 5 One of the most characteristic aberrations, likely influential in altering intracellular signaling and subsequent aberrant responses of T-cells, is the specific downregulation of the CD3ζ component of the T-cell receptor complex, 6, 7 CD247. In SLE T-cells, this molecule is specifically replaced by the Fc receptor γ chain that is coupled with a different intracellular signaling pathway. 8 In addition to this demonstrated functional relevance, association of genetic polymorphisms within CD247 with SLE has been discovered. Two reports have provided evidence for such an association, identifying two 3′ untranslated region (UTR) single-nucleotide polymorphisms (SNPs) in strong linkage disequilibrium (LD) and showing association with differential CD3ζ expression 9 as well as with SLE 10 in a European population. More recently, several SNPs within CD247 (particularly in intron 1) were also found associated with SLE in Asian populations. 11 Because the epidemiology of SLE has demonstrated that the prevalence of disease differs substantially across ethnic groups, it is logical that there exists significant genetic 12, 13 This has been supported by the differential findings obtained in genome-wide association studies (GWAS) performed in different populations, [14] [15] [16] [17] [18] [19] with novel loci such as RASGRP3 and WDFY4 found to be associated with SLE in Asian but not European populations. In this study, in order to further test the association of CD247 gene with SLE in different populations, we typed 44 SNPs in a large multiethnic sample with a total of 17 003 individuals.
RESULTS

Association study and imputation analysis in the Asian population
The strongest associations were found in the Asian population (11 Table 1 ; also see Figure 1 ). The most associated rs858554 (SNP 31, minor allele frequency in controls = 13%) reached a significance of P = 4.99 × 10 − 4 (odds ratio (OR) (95% confidence interval (CI)) = 1.32 (1.13-1.55)) and a corresponding P = 1.50 × 10 − 2 after Bonferroni correction for multiple testing. Several of the 11 significant SNPs were in very strong LD (r 2 Figure 2 ). This suggests the existence of multiple genetic variants within CD247 implicated in SLE.
Haplotypic association analysis in the Asian population identified a five-marker haplotype containing five SNPs in intron 1 (rs12141731-rs2949655-rs16859085-rs12144621-rs858554; G-G-A-G-A; identified in Figure 2 ) showing robust association with SLE (P hap = 2.12 × 10 − 5 ).
Even though we investigated 42 SNPs in CD247, a proportion of the genetic variation in the region was not assessed because of the size of the gene (Figure 1 ). To evaluate the potential association of unobserved polymorphisms in this gene in the Asian population, we imputed SNPs in chromosome 1 using data from HapMap as well as the genotypes observed at the 30 fully genotyped markers. In the CD247 gene, we obtained imputed genotypes meeting minimum quality standards (minor allele frequency in controls ⩾ 0.05 and SNP INFO ⩾ 0.8) for 51 SNPs, including 9 of the genotyped SNPs ( Figure 1 ; identified with the SNP ID in Supplementary Table S1 ). Previously genotyped SNPs were imputed using the observed genotypes at the other SNPs, and a concordance rate 485% between imputed and observed genotypes was obtained ( Figure 1 ).
From the 51 imputed SNPs, 27 (including 7 of the genotyped SNPs) were associated with SLE susceptibility (P ⩽ 0.05) (Supplementary Table S1, Figure 1 ), the most significant of which were rs858557, rs858556 and rs858553 (all with: P = 4.82 × 10 − 4 , SNP INFO = 1.04). All these polymorphisms are located in intron 1 close to our most strongly associated typed SNP rs858554. Figure 1 . Results of the association tests with SLE for observed and imputed SNPs in the CD247 gene. The scaled diagram of the CD247 gene structure is represented above the plots: exons are represented by black boxes and marked with its corresponding number; 5′UTR and 3′UTR are represented by gray boxes; introns are represented by black lines between exons. The top plot shows the negative logarithms of the Pvalues for genotypic association (under the additive model and adjusted for the first three principal components and gender) for the polymorphisms successfully genotyped by us in the Asian population (green dots), and the significant SNPs from GWAS data 19 (dark blue dots; personal communication from authors, May 2012). The second plot displays the negative logarithms of the P-values for 51 SNPs in chromosome 1 imputed with high quality (SNPs with a minor allele frequency ⩾ 0.05 and SNP INFO ⩾ 0.80, gray dots), including SNPs that were previously genotyped (green dots). The bottom graph displays the rate of concordance of observed and imputed genotypes. Broken horizontal lines in the top and second plots indicate a significance level of P = 0.05. In all the plots, the SNPs that had been initially genotyped are represented with green dots.
Our most significant findings are consistent with those from a previous report in Asian populations 11 that resulted from the examination of GWAS data. 19 In these studies, 14 SNPs in the CD247 gene locus (including both upstream and downstream regions of the gene) were found to be significantly associated with SLE, five of which were inside the CD247 gene (personal communication from Yang et al., 19 May 2012), all located in intron 1 (as indicated by the dark blue dots in Figure 1 ). In our study, the 11 significant SNPs were also all located in intron 1 (although in different variants; as indicated by the green dots in Figure 1 ).
The plot of pairwise LD of the genotyped SNPs in our Asian samples ( Figure 2 ) showed very similar LD patterns to the plot of CHB HapMap samples (Supplementary Figure S1 ), supporting the use of this reference data set to check linkage between the significant SNPs in our Asian cohort and those in CD247 from the GWAS data. 19 We can see that the significant GWAS SNPs and our SNPs (black squares and asterisks, respectively, in Supplementary Figure S1 ) are physically close but in different LD blocks. Namely, the most significant SNPs in both studies, our rs858554 (SNP 31) and the GWAS rs704853, are in two different blocks located in intron 1. Furthermore, all the significant GWAS SNPs are in weak LD (r 2 o 0.25) among themselves and with our associated SNPs (Supplementary Figure S1 ). Taken together, the results of both studies complement each other, pointing to the existence of different variants in the same gene region that are not in strong LD and were observed independently, which strengthens the general result. Imputation did not return results for the top significant variants in Li et al. 11 and GWAS. 19 Non-Asian populations multiethnic association study and meta-analysis Five SNPs were significantly associated with SLE in the European ancestry samples (1.12 × 10 − 2 oP o 4.51 × 10 − 2 ), including four SNPs within intron 1 (SNPs 14, 15, 35 and 36) and one downstream of CD247 (SNP 1). In the other ethnicities, three SNPs were associated in African ancestry (SNPs 6, 24 and 35, 5.92 × 10 − 3 o P o 2.95 × 10 − 2 ) and one SNP in the Hispanic/Amerindian (SNP 36 P = 3.39 × 10 − 2 ) populations ( Figure 3 , Supplementary  Table S2 ). None of these SNPs, however, remained significant upon Bonferroni's correction for multiple testing. Nevertheless, several of these significant SNPs were common to the associated SNPs in the Asian cohort, namely, SNPs 14, 35 and 36 in the European ancestry, SNPs 24 and 35 in the African ancestry and SNP 36 in the Hispanic/Amerindian ancestry ( Figure 3 ).
The significant haplotype identified in the Asian population was not associated in these three populations although the LD structures were similar (Supplementary Figure S2) .
Cross-ethnic meta-analysis of the four populations, assuming an additive genetic model and adjusted for population proportions, showed five SNPs with significant P-values (1.40 × 10 − 3 o P o 3.97 × 10 − 2 ), all located in intron 1 of CD247 (Table 2, Figure 3 ). One marker was still significant after Bonferroni correction for multiple testing: rs704848 (SNP 36) with P meta = 2.66 × 10 − 2 .
DISCUSSION
In this multiethnic association study, we independently validated and extended the previous association of CD247 genetic variants with SLE, primarily in the Asian population. Two studies have previously found an association of the 3′UTR of this gene with reduced expression of CD3ζ 9 and SLE. 10 In contrast, our discoveries highlight genetic association in Asians in the 5′ region (intron1) of CD247. This is consistent with recent studies performed in Asian populations. 11 Considering the ethnic heterogeneities in the epidemiology of SLE, 12,13 these observations suggest a particular association of CD247 genetic variants in Asian populations. Although pointing to the heterogeneity in the genetic association of CD247 with SLE, most importantly, these results further support and highlight the implication of this gene in SLE.
The CD247 gene spans 88 kb and has been mapped to chromosome 1q24.2. The first intron spans about 78 kb, followed by seven other exons of the gene. The 11 significant SNPs in the Asian population and 78% of the significant SNPs in the other three populations tested lie in intron 1, suggesting a possible role in the regulation of CD247 expression. 11 This region is further highlighted by the imputation analysis (27 imputed SNPs reached significance) and haplotypic association (P hap = 2.12 × 10 − 5 ) in the Asians and by an overall significant meta-analysis of all the four populations.
Gorman et al. 9 found two SNPs (in high LD) rs1052230 and rs1052231 in 3′UTR of the gene being associated with CD247 expression levels in both SLE patients and healthy controls. However, only weak association with disease risk was found for haplotypes in the 3′UTR region of the gene. In addition, Warchoł et al. 10 found that rs1052231 conferred increased risk of incidence of SLE. In our study, SNP rs1052230 did not show significant disease association (P = 0.2575), and imputation on rs1052231 was neither significant (P = 0.2950). These discrepancies from our results suggest an implicit genetic heterogeneity in the different populations while principally providing further evidence of the involvement of CD247 in SLE susceptibility.
Interestingly, other studies on autoimmune diseases also reported their main findings in intron 1 of CD247, 20-25 supporting a common mechanism behind the involvement of this gene in the etiology of these autoimmune disorders. A recent GWAS on systemic sclerosis, an autoimmune disease that shares some autoantibody and clinical features with SLE, identified CD247 as a major susceptibility gene (rs2056626, located in intron 1, P = 3.39 × 10 − 9 ). 20 This association with systemic sclerosis was replicated in two other cohorts. 21, 22 In our study, rs2056626 was not genotyped but was found to be significantly associated when imputed (P = 1.42 × 10 − 2 ). Furthermore, this SNP is in strong LD (r 2 = 0.75) with rs7523907 (SNP 14) (using HapMap data; release 23), which had P = 3.00 × 10 − 2 in our study. A meta-analysis of GWAS in celiac disease and rheumatoid arthritis identified several non-HLA (human leukocyte antigen) shared loci, among which is the SNP rs864537 in intron 1 of CD247 (P combined = 2.20 × 10 − 11 ). 23 In our study, rs864537 was not genotyped (or imputed), and it is not in LD with any of our SNPs (using HapMap data; release 23). Several GWAS also showed suggestive association of CD247 with Crohn's disease (summarized in Wang et al. 24 ), with the relevant SNPs being rs704853, rs12061855, rs1799704, rs2988276 and rs870875 (P = 1.80 × 10 − 3 oP o 2.40 × 10 − 2 ). The SNP rs870875 was tested in our study but with no association, and rs2988276 had a borderline association using imputed data (P = 3.98 × 10 − 2 ). None of these SNPs is in high LD with any of our variants (using HapMap data; release 23). Recently, a novel association with CD247 (rs1773560, in intron 1) was also identified for juvenile idiopathic arthritis (P = 2.57 × 10 − 7 ). 25 This SNP showed an imputed association in our study (P = 1.83 × 10 − 2 ) and is in strong LD (r 2 = 0.71) with rs7523907 (SNP 14, significant in our SLE study) and with rs2056626 (r 2 = 0.94) (found associated with systemic sclerosis) (using HapMap data; release 23). Genetic association of CD247 with SLE M Martins et al T-cells are considered to be central to the pathogenesis of SLE, because aberrations in their functionality are very likely strongly contributing to the altered immune responses and overproduction of pathogenic autoantibodies. 26 CD247 encodes the TCR zeta chain (CD3ζ), a component of the TCR-CD3 complex. 27 TCRζ is a pivotal component of the TCR signaling machinery and vital for T-cell activation. A defective expression of the CD3ζ-chain has been associated not only with autoimmune diseases, including SLE 6, 7, 28 and rheumatoid arthritis, 29, 30 but also other conditions, such as tumors and chronic infection. 31 It is one established reason for various functional alterations in T-cells in these conditions that TCR signaling through CD3ζ is replaced by FcRγ 8 and its associated Syk pathway that enhances calcium and cytoskeletal reactions. 32 This mechanism could be responsible for the shared association of several autoimmune diseases with CD247. Another effect that seems particularly relevant for SLE is that CD3ζ signaling reportedly augments interleukin-2 production, 7 indicating that its loss likely contributes to the defective interleukin-2 production that characterizes T-cells in SLE. 33 Potential mechanisms as per how autoimmunity-associated genetic variants exert their effects may include differences in expression, splicing and posttranslational processing, but their relevance is still not clear. 34 Our findings confirm the relevance of these effects for SLE pathogenesis and highlight that the development of SLE is influenced by mechanisms shared with other autoimmune diseases, which involve a role of the TCR signaling pathway that should be further characterized. This is corroborated also by several GWAS-identified risk loci shared between SLE and other autoimmune disorders pointing to common immunological mechanisms. 35 In this study, we provide a replication establishing CD247 as a genetic risk factor for SLE, which generates new implications for the pathogenesis of the disease and might lead to new therapeutic targets for disease management.
PATIENTS AND METHODS
Study design
The genotype data used in this study were generated as a part of a joint effort of 440 investigators from around the world. These investigators contributed samples, funding and hypotheses on a combined array containing~35 000 SNPs (Supplementary Figure S1 from Lessard et al. 36 ). The Oklahoma Medical Research Foundation served as the coordinating center, ran the arrays and sent the data to a central facility for quality control at Wake Forest Medical Center. These data were then distributed back to the investigators, who requested the SNPs, for final analysis of their own respective hypotheses.
Patient and control samples
A total of 17 003 samples (8922 SLE patients and 8077 healthy controls; 4 with unknown disease status) from four main populations with Asian, Hispanic/Amerindian, European and African ancestry were initially enrolled in this multiethnic study. Details regarding the characteristics of the study participants in each dataset were previously described. 37 The samples were assembled at the Oklahoma Medical Research Foundation after collection in multiple institutions around the world, following ethics committee approval and informed consent in accordance with the Declaration of Helsinki. Patients were classified with SLE based upon using the American College of Rheumatology criteria. 38 Genotyping A total of 44 SNPs in the CD247 region and 347 ancestral-informative markers (AIMs) were genotyped using the Illumina iSelect technology (Illumina, San Diego, CA, USA). Extensive quality control was performed following stringent criteria to select the SNPs to be used in the analysis, namely, well-defined cluster scatter plots, 490% call rates across the entire study and, in this specific set of SNPs, deviations from Hardy-Weinberg equilibrium with Po0.01 in controls and Po0.0001 in cases (using the PLINK 39 Hardy-Weinberg analysis), total proportion missing o5% and P40.05 for differential missingness between cases and controls. Only SNPs with minor allele frequency 45% in both the case and control groups were analyzed for association in each population.
Samples with o90% call rate, excess heterozygosity, as well as firstdegree relatives, duplicates and individuals with self-reported vs genetically determined gender inconsistencies were excluded from the analysis as previously described. 37 EIGENSTRAT 40 was used to identify population substructure within the samples based on AIMs. The AIMs were selected to distinguish four continental ancestral populations: Africans, Europeans, American Indians, and East Asians. 41, 42 Principal components from EIGENSTRAT outputs were used to identify genetic outliers from each population cluster (as described in Lessard et al. 37 ). After quality control, a total of 1452 samples were excluded. The final meta-dataset used in the analysis consisted of 15 551 subjects (8214 SLE cases and 7337 controls): 2488 Asians, 2247 Hispanic/ Amerindians, 7248 Europeans, and 3568 Africans. Characteristics of the study participants in each dataset are described in Table 3 .
Two SNPs (rs1214603 and rs10918694) were excluded owing to genotyping failure. Of the 42 SNPs with genotyping results, 3 were further excluded in all the four populations (rs2995087, rs1214604 and rs704855), 9 more in the Asians, 9 more in the Hispanic/Amerindians, 8 more in the Europeans and 6 more in the African ancestry (African American/Gullah) samples ( Table 1 , Supplementary Table S2 ) owing to quality-control issues previously described. 37 A final set of 39 SNPs were successfully genotyped in at least one population (SNP ID 1-39; listed in Table 1 and Supplementary Table S2 ): 30 in the Asian population; 30 in the Hispanic/Amerindians; 31 in the Europeans; and 33 in the Africans.
Statistical analysis
Multiple logistic regression (PLINK; 39 additive genetic model) was used to test for SLE association. Analysis was adjusted for the first three principal components calculated from AIMs and gender. Conditional analyses based on the most strongly associated SNP (rs858554) (results expressed as conditional P (P cond ) values) were performed with logistic regression using PLINK, 39 (additive genetic model; adjusted for the first three principal components and gender). Results were considered significant below the conventional level of Po0.05. Correction for multiple testing was performed using the conservative Bonferroni method.
Haplotypic association was tested using PLINK 39 sliding window analysis. LD plots for each cohort were created using Haploview 4.2. 43 We also used the HapMap CHB (Han Chinese from Beijing, China, n = 84) reference data set (downloaded from the International HapMap Project website; HapMap3, release 2; chr1:165663570..165742500) to construct the LD plot of the reference Asian population and check linkage between the significant SNPs in our Asian cohort and those in CD247 from the GWAS data that we had access to. 19 Table 3 . Demographic characteristics of the four populations (after quality control)
Population ancestry
Samples after QC Cases Age of onset (mean ± s.d.)
Controls Male Female
Meta-analysis of the 19 SNPs with association data for the four populations were calculated using Stouffer's Z trend method implemented in METAP, 44 weighted by sample size and taking into account effect directions.
Imputation analysis
SNPs not directly genotyped in the CD247 region for the Asian population, where we had the strongest associations, were imputed with PLINK 39 using HapMap Phase II and specific reference panels for the Asian population (Release 23; 161 230 SNPs on chromosome 1, 90 JPT+CHB founders). For every imputed SNP, PLINK provides an information content metric INFO, ranging from 0 to 1 (although it can be 41 occasionally). A higher INFO value generally means a better SNP imputation. All imputed SNPs with minor allele frequency o0.05 and with INFOo0.8 were excluded. For genotyped SNPs, PLINK calculates the concordance rate among the observed and imputed genotypes (Figure 1 ).
